XML 33 R24.htm IDEA: XBRL DOCUMENT v3.25.4
SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2025
Disclosure of operating segments [abstract]  
Schedule of revenue by major product group
   
Six-month period ended
  
Revenue
  
June 30,2025
US$‘000
    
June 30,2024
US$‘000
  
Clinical laboratory goods
    
14,404
      
20,397
  
Clinical laboratory services
    
1,953
      
2,582
  
Point-of-care products
    
2,044
      
7,568
  
 
                
 
    
18,401
      
30,547
  
Schedule of segment results by geographical area
 
        
Rest of World
        
 
  
Americas
    
Ireland
    
Other
    
Total
  
Six-month period ended June 30, 2025
  
US$‘000
    
US$‘000
    
US$‘000
    
US$‘000
  
Result before restructuring costs, impairment and unallocated expenses
    
(324
)
    
(6,620
)
    
(103
)
    
(7,047
)
Restructuring costs
    
(421
)
    
(1,980
)
    
(58
)
    
(2,459
)
Once off costs
    
186
      
-
      
-
      
186
  
Impairment
    
(28
)
    
-
      
-
      
(28
)
 
                                
Result after restructuring costs and impairment
    
(587
)
    
(8,600
)
    
(161
)
    
(9,348
)
Unallocated expenses *
                            
(685
)
 
                            
 
  
Operating loss
                            
(10,033
)
Net financing expense
                            
(4,431
)
 
                                
Loss before tax
                            
(14,464
)
Income tax expense
                            
(300
)
 
                                
Loss for the period on continuing operations
                            
(14,764
)
Profit for the period on discontinued operations
                            
-
  
 
                                
Loss for the six-month period
                            
(14,764
)
 
 
The distribution of segment results by geographical area was as follows:
 
 
        
Rest of World
        
 
  
Americas
    
Ireland
    
Other
    
Total
  
Six-month period ended June 30, 2024
  
US$‘000
    
US$‘000
    
US$‘000
    
US$‘000
  
Result before restructuring costs, impairment and unallocated expenses
    
(1,050
)
    
(2,268
)
    
(26
)
    
(3,344
)
Restructuring costs
    
(1,303
)
    
(636
)
    
-
      
(1,939
)
Impairment
    
(446
)
    
-
      
-
      
(446
)
 
                                
Result after impairment
    
(2,799
)
    
(2,904
)
    
(26
)
    
(5,729
)
Unallocated expenses *
                            
(1,364
)
 
                            
 
  
Operating loss
                            
(7,093
)
Net financing expense
                            
(3,045
)
 
                                
Loss before tax
                            
(10,138
)
Income tax credit
                            
64
  
 
                                
Loss for the period on continuing operations
                            
(10,074
)
Profit for the period on discontinued operations
                            
-
  
 
                                
Loss for the six-month period
                            
(10,074
)
 
 *
Unallocated expenses represent head office general and administration costs of the Group, which cannot be allocated to the results of any specific geographical area.
Schedule of segment assets and segment liabilities by geographical area
 
        
Rest of World
        
 
  
Americas
    
Ireland
    
Other
    
Total
  
As at June 30, 2025
  
US$‘000
    
US$‘000
    
US$‘000
    
US$‘000
  
Assets and liabilities
                        
Segment assets
    
34,124
      
59,968
      
16
      
94,108
  
Unallocated assets:
                                
Income tax assets (current and deferred)
                            
3,977
  
Cash and cash equivalents and short-term investments
                            
1,546
  
                                 
Total assets as reported in the Statement of Financial Position
                            
99,631
  
 
                                
Segment liabilities
    
94,077
      
50,016
      
42
      
144,135
  
Unallocated liabilities:
                                
Income tax liabilities (current and deferred)
                            
5,034
  
 
                                
Total liabilities as reported in the Statement of Financial Position
                            
149,169
  
 
 
        
Rest of World
        
 
  
Americas
    
Ireland
    
Other
    
Total
  
As at December 31, 2024
  
US$‘000
    
US$‘000
    
US$‘000
    
US$‘000
  
Assets and liabilities
                        
Segment assets
    
32,798
      
61,254
      
-
      
94,052
  
Unallocated assets:
                                
Income tax assets (current and deferred)
                            
4,071
  
Cash and cash equivalents and short-term investments
                            
5,167
  
                                 
Total assets as reported in the Statement of Financial Position
                            
103,290
  
 
                                
Segment liabilities
    
84,863
      
48,621
      
62
      
133,546
  
Unallocated liabilities:
                                
Income tax liabilities (current and deferred)
                            
4,925
  
 
                                
Total liabilities as reported in the Statement of Financial Position
                            
138,471